OP-002 The New Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants




Aim


The aim of the current study was to compare the new oral anticoagulants with warfarin in patients with atrial fibrillation and diabetes.




Methods


Three large randomized trials of the new oral anticoagulants (n = 14415) were included in this meta-analysis. Subgroup analysis of diabetic patients with atrial fibrillation was performed. The RE-LY trial had 2 doses of dabigatran. Therefore, 2 subgroups were included in the meta-analysis.




Methods


Three large randomized trials of the new oral anticoagulants (n = 14415) were included in this meta-analysis. Subgroup analysis of diabetic patients with atrial fibrillation was performed. The RE-LY trial had 2 doses of dabigatran. Therefore, 2 subgroups were included in the meta-analysis.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. OP-192 The Relationship of The Healthy Lifestyle Behaviors and Cardiovascular Disease Risk Factors Knowledge Level of Patients with Cardiovascular Disease and Their Relatives
  2. PP-023 Coronary Dissection and Intramural Hematoma in a Patient with Acute Anterior Myocardial Infarction
  3. PP-055 Association between Coronary Artery Disease and Hepatitis C Virus Seropositivity
  4. PP-087 QRS-T Angle is Wider in Patients with Hypertension

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-002 The New Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants

Full access? Get Clinical Tree
Get Clinical Tree app for offline access